Literature DB >> 7848615

Female preponderance for lisinopril-induced cough in hypertension.

I Os1, B Bratland, B Dahlöf, K Gisholt, J O Syvertsen, S Tretli.   

Abstract

In a double-blind double-dummy multicenter study, patients with mild to moderate essential hypertension were randomized to receive either nifedipine (n = 416, 47.6% women) or lisinopril (n = 412, 50% women), and side effects were registered by specific questioning, by spontaneous reports, and by use of visual analog scales. Cough was spontaneously reported to occur in 8.5% with lisinopril compared to 3.1% with nifedipine. Women treated with lisinopril reported cough spontaneously three times more often than men, 12.6% v 4.4%, whereas no differences between the sexes were observed during the placebo period or during nifedipine treatment. Similar gender differences were observed during specific questioning. Furthermore, nonsmokers reported an increase in cough more often than did smokers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848615     DOI: 10.1093/ajh/7.11.1012

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  17 in total

1.  Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany.

Authors:  B Bischoff; Sigmund Silber; B M Richartz; L Pieper; J Klotsche; H-U Wittchen
Journal:  Clin Res Cardiol       Date:  2006-07-03       Impact factor: 5.460

2.  Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels.

Authors:  Folkert W Asselbergs; Scott M Williams; Patricia R Hebert; Christopher S Coffey; Hans L Hillege; Gerjan Navis; Douglas E Vaughan; Wiek H van Gilst; Jason H Moore
Journal:  Genomics       Date:  2007-01-05       Impact factor: 5.736

Review 3.  Gender Differences in Antihypertensive Treatment: Myths or Legends?

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Claudia Agabiti Rosei; Anna Paini
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-22

4.  Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough.

Authors:  Stefan Vegter; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

Review 5.  Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension.

Authors:  Paolo Di Giosia; Paolo Giorgini; Cosimo Andrea Stamerra; Marco Petrarca; Claudio Ferri; Amirhossein Sahebkar
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

Review 6.  Hypertension Across a Woman's Life Cycle.

Authors:  Nanette K Wenger; Anita Arnold; C Noel Bairey Merz; Rhonda M Cooper-DeHoff; Keith C Ferdinand; Jerome L Fleg; Martha Gulati; Ijeoma Isiadinso; Dipti Itchhaporia; KellyAnn Light-McGroary; Kathryn J Lindley; Jennifer H Mieres; Mary L Rosser; George R Saade; Mary Norine Walsh; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2018-04-24       Impact factor: 24.094

7.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

8.  The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis.

Authors:  Stefan Vegter; Pieter de Boer; Klaas Willem van Dijk; Sipke Visser; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

9.  Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.

Authors:  Takeshi Morimoto; Tejal K Gandhi; Julie M Fiskio; Andrew C Seger; Joseph W So; E Francis Cook; Tsuguya Fukui; David W Bates
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

Review 10.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.